Journal
ACTA PHARMACOLOGICA SINICA
Volume 33, Issue 9, Pages 1131-1140Publisher
ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/aps.2012.109
Keywords
computational drug discovery; target identification; lead discovery
Funding
- State Key Program of Basic Research of China [2009CB918502]
- National Natural Science Foundation of China [21021063, 20972174, 91029704]
- Chinese Academy of Sciences [XDA01040305]
- National High Technology Research and Development Program of China [2012AA020302]
Ask authors/readers for more resources
Computational drug discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved. In this review, we present an overview of these important computational methods, platforms and successful applications in this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available